We are live on ! Find out more
NIVF

NewGenIvf
NIVF

0 hedge funds and large institutions have $578 invested in NewGenIvf in 2025 Q3 according to their latest regulatory filings, with 0 funds opening new positions, increasing their positions, reducing their positions, and 1 closing their positions.

New
Increased
Maintained
Reduced
Closed

100% less funds holding

Funds holding: 1 → 0 (-1)

100% less capital inflows, than outflows

Capital inflows: $0 | Capital outflows: $10.8K

100% less first-time investments, than exits

New positions opened: 0 | Existing positions closed: 1

Holders
–
Holders Change
-1
Holders Change %
-100%
% of All Funds
–
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
–
Increased
–
Reduced
–
Closed
1
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

No buyers this quarter

Top Sellers

Rank Fund Capital Flow
1
Marex Group
Marex Group
-$10.4K
2
UBS Group
UBS Group
Switzerland
-$363

NIVF Hedge Fund Activity: Q3 2025 in Review

0 of the 7,648 institutional investors tracked by Wall St. Rank reported a position in NewGenIvf (NIVF) for Q3 2025, worth a combined $578 — down 95% from $10.8K a quarter earlier.

Sellers outnumbered buyers: 1 fund closed out of NIVF and 0 opened new positions — a net loss of 1 holder — while 0 trimmed existing stakes and 0 added.

The largest seller was Marex Group, exiting entirely with an estimated $10.4K sold.

  • 0 institutional investors held NewGenIvf (NIVF) as of Q3 2025, down from 1 in Q2 2025.
  • Funds reported $578 of NewGenIvf stock for Q3 2025, down 95% quarter-over-quarter.
  • 0 funds opened new NewGenIvf positions in Q3 2025 and 1 closed out, a net change of -1 holder.
  • The largest NewGenIvf seller in Q3 2025 was Marex Group, an estimated $10.4K sold.

Based on aggregated 13F filings for Q3 2025.